CP-461, formerly known as OSI-461, is a PDE2A/5A inhibitor potentially for the treatment of renal cell carcinoma, prostate cancer, and Crohn's disease. References: Singh R, Frobel J, Cadeddu RP, Bruns I, Schroeder T, Brünnert D, Wilk CM, Zerbini LF, Haas R, Czibere A. The novel compound OSI-461 induces apoptosis and growth arrest in human acute myeloid leukemia cells. Ann Hematol. 2012 Feb;91(2):173-81. doi: 10.1007/s00277-011-1282-4. PubMed PMID: 21717102.

纯度：≥98%

CAS：227619-92-3